Medicine and Dentistry
Antioxidant
46%
Aptamer
93%
Argon Plasma Coagulation
46%
Cancer Cell
28%
Chronic Hepatitis C
93%
Circular Dichroism
13%
Clinical Study
15%
Cohort Effect
46%
Conjugate
18%
Diseases
23%
DNA Polymorphism
46%
Drug Megadose
26%
Enteric Feeding
15%
Epithelial Cell Adhesion Molecule
93%
Esophagus Mucosa
46%
Fibrosis
23%
Gastroenterostomy
46%
Gastrointestinal Secretion
15%
Health Service
46%
Hemochromatosis
46%
Hepatitis C
63%
Hepatitis C Virus
93%
Hepatocellular Carcinoma
27%
Infection
27%
Interferon
46%
Iron
23%
Life Expectancy
11%
Liver Biopsy
31%
Liver Cirrhosis
39%
Liver Disease
58%
MCF-7
14%
Nausea and Vomiting
15%
Neocarzinostatin
93%
Obstruction
15%
Pancreas Cancer
31%
Pancreas Carcinoma
46%
Placebo
40%
Placebo-Controlled Study
46%
Prevalence
13%
Primary Biliary Cirrhosis
46%
Prokinetic Agent
15%
Pruritus
54%
Pulse Rate
46%
Ribavirin
46%
Stomach Mucosa
46%
Superior Mesenteric Artery Syndrome
15%
Symptomatic Treatment
15%
Tissue Injury
35%
Tumor Cell
53%
Virus Antibody
19%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Pain
7%
Amino Acid
6%
Antioxidant
46%
Apoptosis Assay
9%
Aptamer
93%
Aromatic Amino Acid
6%
Chronic Hepatitis
7%
Chronic Hepatitis C
46%
Clinical Trial
31%
Combination Therapy
15%
Comorbidity
15%
Diseases
7%
Double Stranded DNA
16%
Edema
7%
Epithelial Cell Adhesion Molecule
93%
Epithelium Tumor
6%
Ethanol
15%
Fibrosing Alveolitis
7%
Flow Cytometry
9%
Hemodialysis
7%
Hepatitis C
78%
Hepatitis C Virus
93%
Infection
15%
Infrared Spectroscopy
6%
Intermolecular Interaction
13%
Liver Cell Carcinoma
15%
Liver Cirrhosis
31%
Liver Disease
23%
Malaise
23%
Malignant Neoplasm
34%
Necrosis
9%
Neoplasm
60%
Nonhodgkin Lymphoma
7%
Peginterferon
31%
Placebo
40%
Placebo-Controlled Study
46%
Prevalence
7%
Primary Biliary Cirrhosis
46%
Pruritus
54%
Ribavirin
78%
Side Effect
46%
Streptomyces
6%
Symptomatology
7%
Tablet
7%
Tattoo
7%
Therapeutic Effect
7%
Tissue Injury
7%
Varicosis
7%
Virus Antibody
7%
Zinostatin
93%
Immunology and Microbiology
Allele
5%
Antibody Response
46%
Cancer Cell
28%
Cell Cycle
14%
Common Variable Immunodeficiency
6%
Conjugate
18%
DNA Polymorphism
46%
Drug Megadose
10%
ELISA
7%
Epithelial Cell Adhesion Molecule
46%
Hepatitis
7%
Hepatitis C
100%
Hepatitis C Virus
93%
Interferon Type I
46%
Peginterferon Alfa-2a
5%
Prevalence
5%
Programmed Cell Death
18%
RNA Virus
15%
Single Nucleotide Polymorphism
10%
Tumor Cell
46%
Viral Load
46%
Virus Core
39%
Western Blot
7%